Business
Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial Officer of the Company
Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial Officer of the Company.
About this update from Wellbeing Digital Sciences Inc.
[{"type":"text","content":"\n VANCOUVER, British Columbia, June 15, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc.  (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, is very pleased to announce the appointment of Mr. Terry Zimaro to the position of Chief Financial Officer. Mr. Zimaro is a Chartered Professional Accountant who brings over 20 years of public and private company experience in a wide range of finance functions, in particular specializing in high-growth environments, within various industries including psychedelics. He has enabled companies to maximize profitability, operational efficiencies, and enterprise value. “I am very excited to join Wellbeing Digital Sciences. The Company has a unique value proposition and a strong foundation from which Wellbeing will be able to grow and execute on its vision and mission to fundamentally change the mental health industry through enhanced mental health services and treatments,” stated, Terry Zimaro, CFO. Wellbeing’s CEO, Najla Guthrie commented \"we are pleased to have Terry join our team at an exciting time for the Company. His extensive financial experience, combined with his strong leadership skills will enable him to make an immediate impact on our business. As CFO, Terry is another key strategic addition to our team, and I look forward to working together and seeing his impact on our corporate strategy and growth opportunities.” About Wellbeing Digital ScienceWellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co. On behalf of: Najla GuthrieChief Executive OfficerW...